Published in Am J Dis Child on October 01, 1965
Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies. Br Med J (1968) 5.54
Immunodepression by mammalian viruses and plasmodia. Proc R Soc Med (1970) 2.43
Specific immunoglobulins in infants with the congenital rubella syndrome. J Hyg (Lond) (1976) 1.83
Abnormalities of in vitro lymphocyte responses during rubella virus infections. J Exp Med (1968) 1.82
Laboratory diagnosis of rubella virus infections. Can Med Assoc J (1973) 1.62
Maternal rubella and its effect on the foetus. Arch Dis Child (1967) 1.59
Separation of immunoglobulin M (IgM) essentially free of IgG from serum for use in systems requiring assay of IgM-type antibodies without interference from rheumatoid factor. J Clin Microbiol (1980) 1.56
Rubella virus carrier cultures derived from congenitally infected infants. J Exp Med (1966) 1.45
Immunosuppression during influenza virus infection. Infect Immun (1974) 1.45
Clinico-pathological study of thymic dysplasia. Arch Dis Child (1968) 1.25
Laboratory diagnosis of rubella: past, present and future. Epidemiol Infect (1991) 1.13
Humoral immunity in congenital rubella. Clin Exp Immunol (1967) 0.98
BK antibody and virus-specific IgM responses in renal transplant recipients, patients with malignant disease, and healthy people. Br Med J (1977) 0.96
Immunoglobulins in umbilical cord plasma. I. Healthy infants. Arch Dis Child (1967) 0.94
Impaired cellular immunity to rubella virus in congenital rubella. Infect Immun (1974) 0.90
Thymic hypoplasia due to congenital rubella. Arch Dis Child (1974) 0.88
Pathology of congenital rubella in Jamaica. Arch Dis Child (1967) 0.85
Virus infections of the human foetus. Proc R Soc Med (1966) 0.85
Serology of rubella. Comparison of fluorescent antibody, complement fixation and neutralization tests for diagnosis of current infections and determination of sero-immunity. Calif Med (1967) 0.81
A new look at rubella. Proc R Soc Med (1967) 0.80
Rubella cataract in vitro: Sensitive period of the developing human lens. J Exp Med (1975) 0.80
Breakdown in maternal protection: infections. Proc R Soc Med (1968) 0.79
Immunoglobulins in umbilical cord plasma. II. Congenital deformities, other abnormalities, and multiple pregnancies. Arch Dis Child (1967) 0.77
Virus infections. Proc R Soc Med (1968) 0.77
Congenital rubella: report of two cases with generalized infection. Br Med J (1966) 0.77
Neurology-epitomes of progress: progressive rubella panencephalitis. West J Med (1977) 0.75
[Thrombocytopenic purpura, a new clinical aspect of the congenital rubella syndrome]. Can Med Assoc J (1969) 0.75
Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med (1969) 13.87
Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med (1969) 9.01
Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides. J Exp Med (1969) 8.30
Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med (1969) 6.17
Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med (1966) 5.97
Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med (1970) 4.90
Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis (1972) 4.54
Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis. J Immunol (1973) 4.49
Prevalence of meningococcal serogroups and description of three new groups. Am J Epidemiol (1968) 4.34
Analysis of parameters affecting the solid phase radioimmunoassay quantitation of antibody to meningococcal antigens. J Immunol (1976) 4.02
Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state. J Exp Med (1969) 3.96
Neisseria gonorrhoeae and neisseria meningitidis: extracellular enzyme cleaves human immunoglobulin A. Science (1975) 3.27
Cutaneous reactions and antibody response to meningococcal group C polysaccharide vaccines in man. J Infect Dis (1970) 2.71
Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70. Bull World Health Organ (1971) 2.64
Production and characterization of arbovirus antibody in mouse ascitic fluid. Am J Trop Med Hyg (1967) 2.61
Serologic studies of meningococcal infection and polysaccharide vaccination. J Infect Dis (1971) 2.54
Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis. J Infect Dis (1973) 2.47
Isolation and characterization of a native cell wall complex from Neisseria meningitidis. Infect Immun (1972) 2.43
Pseudomonas colonization in cystic fibrosis. A study of 160 patients. JAMA (1978) 2.42
Pertussis. Medicine (Baltimore) (1975) 2.41
Cross-reactivity of Neisseria gonorrhoeae and Neisseria meningitidis and the nature of antigens involved in the bactericidal reaction. J Infect Dis (1974) 2.24
Identification of an epidemic strain of group C Neisseria meningitidis by bactericidal serotyping. J Infect Dis (1971) 2.17
Herpesvirus infections of the human central nervous system. N Engl J Med (1967) 2.09
Impaired in vitro cell-mediated immunity to rubella virus during pregnancy. N Engl J Med (1973) 2.06
Human antibody response to three meningococcal outer membrane antigens: comparison by specific hemagglutination assays. Infect Immun (1974) 2.00
Encephalopathy and fatty degeneratiof on the viscera in northeastern Thailand. Clinical syndrome and epidemiology. Pediatrics (1971) 2.00
Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis (1971) 1.95
A 51 Cr microassay technique for cell-mediated immunity to viruses. J Immunol (1973) 1.91
Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans. J Infect Dis (1978) 1.86
Aerosol stability of three acute respiratory disease viruses. Proc Soc Exp Biol Med (1967) 1.84
Immunoglobulins in serum and nasal secretions following infection with type 1 parainfluenza virus and injection of inactivated vaccines. J Immunol (1967) 1.79
Respiratory syncytial virus neutralizing activity in nasal secretions following natural infection. Proc Soc Exp Biol Med (1969) 1.79
Physical and biological properties of dengue-2 virus and associated antigens. J Virol (1970) 1.75
Acute respiratory disease and meningococcal infection in army recruits. JAMA (1967) 1.73
Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol (1999) 1.69
A radioactive antigen-binding assay for Neisseria meningitidis polysaccharide antibody. J Immunol (1972) 1.54
Immunoepidemiology of meningococcal disease in military recruits. I. A model for serogroup independency of epidemic potential as determined by serotyping. J Infect Dis (1977) 1.54
Meningococcal infections. 1. Prevalence of serogroups causing disease in US Army personnel in 1964-70. Bull World Health Organ (1971) 1.50
Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune sera. J Exp Med (1979) 1.49
Air sampling for respiratory disease agents in army recruits. Bacteriol Rev (1966) 1.48
Role of food allergy in serous otitis media. Ann Allergy (1994) 1.40
Familial thymic aplasia. Attempted reconstitution with fetal thymus in a Millipore diffusion chamber. N Engl J Med (1972) 1.37
Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines. Am J Epidemiol (1971) 1.36
In vitro synergism between interferons and human lymphotoxin: enhancement of lymphotoxin-induced target cell killing. J Immunol (1983) 1.35
Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity. J Infect Dis (1974) 1.34
Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). Am J Trop Med Hyg (1970) 1.33
Glomerular microtubules of systemic lupus erythematosus. Lancet (1970) 1.33
Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis (1971) 1.33
Evaluation of orally administered antibiotics for treatment of upper respiratory infections in Thai children. J Pediatr (1971) 1.32
Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines. N Engl J Med (1969) 1.32
Ideal target organism for quantitative bactericidal assays. Infect Immun (1978) 1.31
Maturation of the rabbit alveolar macrophage during animal development. III. Phagocytic and bactericidal functions. Pediatr Res (1977) 1.31
Herpes simplex virus infections of the nervous system. Problems in laboratory diagnosis. Arch Neurol (1968) 1.27
Specific impairment of cell-mediated immunity in mothers of infants with congenital infection due to cytomegalovirus. J Infect Dis (1977) 1.26
Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971. Am J Epidemiol (1973) 1.26
Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J (1992) 1.26
Recovery of dengue viruses from patients during epidemics in Puerto Rico and East Pakistan. Am J Trop Med Hyg (1966) 1.25
Increased susceptibility of males to infection. Lancet (1969) 1.25
Meningococcal infections. 3. Studies of group A polysaccharide vaccines. Bull World Health Organ (1971) 1.23
Development of specific cellular and humoral immune responses in children immunized with live rubella virus vaccine. J Infect Dis (1974) 1.22
Latex agglutination test for measurement of antibodies to meningococcal polysaccharides. Infect Immun (1972) 1.21
Use of cryopreserved virus-infected target cells in a lymphocytotoxicity 51Cr release microassay for cell-mediated immunity to cytomegalovirus. Infect Immun (1976) 1.20
Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis. Infect Immun (1975) 1.18
Systemic lysostaphin in man--apparent antimicrobial activity in a neutropenic patient. N Engl J Med (1974) 1.16
Age-dependent susceptibility of neonatal rats to group B streptococcal type III infection: correlation of severity of infection and response of myeloid pools. Infect Immun (1982) 1.16
Biologic significance of the secretory A immunoglobulins. Pediatrics (1971) 1.16
Enhancement of Pseudomonas aeruginosa lung clearance after local immunization with a temperature-sensitive mutant. Infect Immun (1983) 1.14
Large-volume air sampling for Meningococci and Adenoviruses. Am J Epidemiol (1968) 1.14
You Can Control Asthma: evaluation of an asthma education program for hospitalized inner-city children. Patient Educ Couns (1991) 1.14
Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract. Infect Immun (1985) 1.14
Congenital anaemia after transplacental B19 parvovirus infection. Lancet (1994) 1.13
Response of children to Neisseria meningitidis polysaccharide vaccines. J Infect Dis (1973) 1.13
Clinical correlation of strain differentiation of Neisseria gonorrhoeae. J Infect Dis (1976) 1.13
Identification of the cell population involved in viral-specific cell-mediated cytotoxicity in man: evidence for T cell specificity. J Immunol (1975) 1.12
Antibody responses to meningococcal polysaccharide vaccines. Infect Immun (1973) 1.11
Respiratory disease and the adenoviruses. Med Clin North Am (1967) 1.11
Meningococcal infections. 5. Duration of polysaccharide-vaccine-induced antibody. Bull World Health Organ (1971) 1.10
Prophylaxis for meningococcal disease. JAMA (1975) 1.09
Large-volume air sampling of human respiratory disease pathogens. Am J Epidemiol (1967) 1.09
Clinical and epidemiological correlates of Pseudomonas typing. J Infect Dis (1974) 1.09
Herpes simplex encephalitis: virologic and serologic study of a patient treated with an interferon inducer. J Pediatr (1971) 1.08
Attempted prophylaxis against meningococcal infection using intramuscular penicillin. Mil Med (1967) 1.08
Maturation of the rabbit alveolar macrophage during animal development. I. Perinatal influx into alveoli and ultrastructural differentiation. Pediatr Res (1977) 1.08
Adult meningoencephalitis caused by herpesvirus hominis type 2. Am J Med (1974) 1.08
Invasive Haemophilus influenzae type f disease. Pediatr Infect Dis J (1995) 1.07
Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement. Infect Immun (1983) 1.06
Characterization of human serum and nasal hemagglutinating antibody to Francisella tularensis. J Immunol (1967) 1.05
Meningococcal infections. 4. Stability of group A and group C polysaccharide vaccines. Bull World Health Organ (1971) 1.05
Chemotactic and candidacidal responses of rabbit alveolar macrophages during postnatal development and the modulating roles of surfactant in these responses. Infect Immun (1984) 1.04
Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A). Pediatrics (1975) 1.04
Adenoviral infection in military recruits. Arch Environ Health (1970) 1.04
Inflammatory responses to Pseudomonas aeruginosa and Staphylococcus aureus in the murine lung. Eur J Respir Dis (1985) 1.03
Poly I:C induces development of diabetes mellitus in BB rat. Diabetes (1992) 1.02
Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells. Transplantation (1991) 1.02